GSK199 (hydro<wbr>chloride)

GSK199 (hydrochloride)

CAT N°: 17489
Price:

From 66.00 56.10

Protein arginine deiminase 4 (PAD4) mediates the transformation of protein arginine into citrulline. Citrullination of proteins has normal roles in gene regulation and pathological roles in immunological and inflammatory diseases.{18134} GSK199 is a reversible inhibitor of PAD4 (IC50 = 200 nM) that binds to the low-calcium form of the enzyme and is selective for PAD4 over PAD1-3.{28376}It is less potent than the related PAD4 inhibitor GSK484 (Item No. 17488), which demonstrates an IC50 value of 50 nM.{28376} GSK199 can inhibit the citrullination of PAD4 target proteins and diminish the formation of neutrophil extracellular traps in mouse neutrophils.{28376}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • [(3R)-3-amino-1-piperidinyl][2-(1-ethyl-1H-pyrrolo[2,3-b]pyridin-2-yl)-7-methoxy-1-methyl-1H-benzimidazol-5-yl]-methanone, monohydrochloride
  • Correlated keywords
    • PAD4 protein arginine deiminase 4 citrullination neutrophil extracellular trap NET GSK-199 PAD
  • Product Overview:
    Protein arginine deiminase 4 (PAD4) mediates the transformation of protein arginine into citrulline. Citrullination of proteins has normal roles in gene regulation and pathological roles in immunological and inflammatory diseases.{18134} GSK199 is a reversible inhibitor of PAD4 (IC50 = 200 nM) that binds to the low-calcium form of the enzyme and is selective for PAD4 over PAD1-3.{28376}It is less potent than the related PAD4 inhibitor GSK484 (Item No. 17488), which demonstrates an IC50 value of 50 nM.{28376} GSK199 can inhibit the citrullination of PAD4 target proteins and diminish the formation of neutrophil extracellular traps in mouse neutrophils.{28376}

We also advise you